Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (91-100 of 789) with videos related to

Pageof 79
Sort By:
Journal of Psychopharmacology (Oxford, England)|July 5, 2021
More than just smoke: Psychopharmacology of cannabinoidsAllan H Young, David J Nutt
Pharmacology Research & Perspectives|August 7, 2019
Compound asset sharing initiatives between pharmaceutical companies, funding bodies, and academia: Learnings and successesAnn G Hayes, David J Nutt
Advances in Alcohol & Substance Abuse|January 1, 1988
Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitorC H Gleiter, D J Nutt
Drug Discovery Today|May 4, 2024
Strengthening Molecular Glues: Design Strategies for Improving Thalidomide Analogs as Cereblon Effectors and Anticancer AgentsMichael J Nutt, Scott G Stewart
Psychopharmacology|January 1, 1988
A single electroconvulsive shock substantially lowers blood glucose levels in obese mice (C57BL/6J ob/ob)C H Gleiter, D J Nutt
The Journal of Pharmacy and Pharmacology|September 1, 1991
Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the ratH C Jackson, D J Nutt
Psychopharmacology|January 1, 1992
Strain differences in sensitivity to the hypothermic effects of benzodiazepine receptor ligands in miceH C Jackson, D J Nutt
Psychopharmacology|January 1, 1988
Repeated electroconvulsive shock increases the number of [3H]desipramine binding sites in rat cerebral cortexC H Gleiter, D J Nutt
Advances in Alcohol & Substance Abuse|January 1, 1988
RO 15-4513 and its interaction with ethanolR G Lister, D J Nutt
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2000
The use of benzodiazepines in anxiety and other disordersS V Argyropoulos, D J Nutt
Pageof 79

Showing results (91-100 of 789) with videos related to

Sort By:
Pageof 79
Journal of Psychopharmacology (Oxford, England)|July 5, 2021
More than just smoke: Psychopharmacology of cannabinoidsAllan H Young, David J Nutt
Pharmacology Research & Perspectives|August 7, 2019
Compound asset sharing initiatives between pharmaceutical companies, funding bodies, and academia: Learnings and successesAnn G Hayes, David J Nutt
Advances in Alcohol & Substance Abuse|January 1, 1988
Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitorC H Gleiter, D J Nutt
Drug Discovery Today|May 4, 2024
Strengthening Molecular Glues: Design Strategies for Improving Thalidomide Analogs as Cereblon Effectors and Anticancer AgentsMichael J Nutt, Scott G Stewart
Psychopharmacology|January 1, 1988
A single electroconvulsive shock substantially lowers blood glucose levels in obese mice (C57BL/6J ob/ob)C H Gleiter, D J Nutt
The Journal of Pharmacy and Pharmacology|September 1, 1991
Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the ratH C Jackson, D J Nutt
Psychopharmacology|January 1, 1992
Strain differences in sensitivity to the hypothermic effects of benzodiazepine receptor ligands in miceH C Jackson, D J Nutt
Psychopharmacology|January 1, 1988
Repeated electroconvulsive shock increases the number of [3H]desipramine binding sites in rat cerebral cortexC H Gleiter, D J Nutt
Advances in Alcohol & Substance Abuse|January 1, 1988
RO 15-4513 and its interaction with ethanolR G Lister, D J Nutt
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2000
The use of benzodiazepines in anxiety and other disordersS V Argyropoulos, D J Nutt
Pageof 79